Circulating microRNA expression profiles associated with systemic lupus erythematosus.
暂无分享,去创建一个
Mårten Segelmark | A. Schetter | C. Harris | S. Knudsen | A. Bengtsson | A. Voss | N. Heegaard | C. Lood | M. Segelmark | T. Hellmark | Curtis C Harris | Steen Knudsen | Anders A Bengtsson | S. Jacobsen | A. Carlsen | Christian Lood | Aaron J Schetter | Thomas Hellmark | Aaron J. Schetter | Søren Jacobsen | Niels H H Heegaard | Anting Liu Carlsen | Christoffer T Nielsen | Anne Voss | C. Nielsen
[1] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[2] D. Bartel,et al. MicroRNAs Modulate Hematopoietic Lineage Differentiation , 2004, Science.
[3] L. Rönnblom,et al. Regulation of the interferon-alpha production induced by RNA-containing immune complexes in plasmacytoid dendritic cells. , 2009, Arthritis and rheumatism.
[4] A. Schetter,et al. Circulating micro‐RNA expression profiles in early stage nonsmall cell lung cancer , 2012, International journal of cancer.
[5] P. Gregersen,et al. The emerging role of interferon in human systemic lupus erythematosus. , 2004, Current opinion in immunology.
[6] Y. Inoue,et al. Circulating miR‐142‐3p levels in patients with systemic sclerosis , 2012, Clinical and experimental dermatology.
[7] Marc Monestier,et al. Microparticles as antigenic targets of antibodies to DNA and nucleosomes in systemic lupus erythematosus. , 2011, Journal of autoimmunity.
[8] M. Hochberg,et al. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.
[9] Daniel B. Martin,et al. Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.
[10] Nan Shen,et al. miR-155 and its star-form partner miR-155* cooperatively regulate type I interferon production by human plasmacytoid dendritic cells. , 2010, Blood.
[11] L. Rönnblom,et al. C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis. , 2009, Arthritis and rheumatism.
[12] S. Gay,et al. The release of microparticles by apoptotic cells and their effects on macrophages , 2005, Apoptosis.
[13] C. Johnsen,et al. Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus. , 2011, Arthritis and rheumatism.
[14] Wentian Li,et al. Elevated Serum Levels of Interferon-Regulated Chemokines Are Biomarkers for Active Human Systemic Lupus Erythematosus , 2006, PLoS medicine.
[15] S. Salah,et al. Expression signature of microRNA-181-a reveals its crucial role in the pathogenesis of paediatric systemic lupus erythematosus. , 2011, Clinical and experimental rheumatology.
[16] D. Gladman,et al. The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. , 1997, Arthritis and rheumatism.
[17] L. Rönnblom,et al. Type I interferon and lupus , 2009, Current opinion in rheumatology.
[18] L. Rönnblom,et al. Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. , 2004, Arthritis and rheumatism.
[19] C. Lutz,et al. Cutting Edge: MicroRNA-181 Promotes Human NK Cell Development by Regulating Notch Signaling , 2011, The Journal of Immunology.
[20] Lin He,et al. Molecular dissection of the miR-17-92 cluster's critical dual roles in promoting Th1 responses and preventing inducible Treg differentiation. , 2011, Blood.
[21] L. Truedsson,et al. Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease. , 2010, Blood.
[22] E. Kroh,et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma , 2011, Proceedings of the National Academy of Sciences.
[23] C. Lau,et al. Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. , 2003, Arthritis and rheumatism.
[24] A. Divekar,et al. Dicer Insufficiency and MicroRNA-155 Overexpression in Lupus Regulatory T Cells: An Apparent Paradox in the Setting of an Inflammatory Milieu , 2011, The Journal of Immunology.
[25] E. Kroh,et al. Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies , 2011, Cancer Prevention Research.
[26] Mark M. Davis,et al. miR-181a Is an Intrinsic Modulator of T Cell Sensitivity and Selection , 2007, Cell.
[27] D. Sackett,et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. , 1992, Arthritis and rheumatism.
[28] R. Voll,et al. Removal of dying cells and systemic lupus erythematosus , 2005, Modern rheumatology.
[29] Wu-xian Li,et al. Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus. , 2012, Translational research : the journal of laboratory and clinical medicine.
[30] Q. Lu,et al. Decreased microRNA-142-3p/5p expression causes CD4+ T cell activation and B cell hyperstimulation in systemic lupus erythematosus. , 2012, Arthritis and rheumatism.
[31] A. Schetter,et al. Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. , 2010, Carcinogenesis.
[32] B. Sundaram,et al. Type I Interferons Are Associated with Subclinical Markers of Cardiovascular Disease in a Cohort of Systemic Lupus Erythematosus Patients , 2012, PloS one.
[33] K. Vickers,et al. MicroRNAs are Transported in Plasma and Delivered to Recipient Cells by High-Density Lipoproteins , 2011, Nature Cell Biology.
[34] P. Tak,et al. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. , 2009, Arthritis and rheumatism.
[35] Igor M. Dozmorov,et al. Identification of Unique MicroRNA Signature Associated with Lupus Nephritis , 2010, PloS one.
[36] J. Lötvall,et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.
[37] D. Baltimore,et al. NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses , 2006, Proceedings of the National Academy of Sciences.
[38] A. Koch,et al. Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosis. , 2012, Arthritis and rheumatism.
[39] G. Rousseau,et al. Existence of a microRNA pathway in anucleate platelets , 2009, Nature Structural &Molecular Biology.
[40] M. Michael,et al. Prox1 expression is negatively regulated by miR-181 in endothelial cells. , 2010, Blood.
[41] Yong Dai,et al. Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients , 2009, Rheumatology International.
[42] G. Sturfelt,et al. Induction of apoptosis in monocytes and lymphocytes by serum from patients with systemic lupus erythematosus − an additional mechanism to increased autoantigen load? , 2004, Clinical and experimental immunology.
[43] Carlo M. Croce,et al. MicroRNAs 17-5p–20a–106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation , 2007, Nature Cell Biology.
[44] Aikaterini S. Papadopoulou,et al. The thymic epithelial microRNA network elevates the threshold for infection-associated thymic involution via miR-29a mediated suppression of the IFN-α receptor , 2011, Nature Immunology.
[45] Lin He,et al. mir-17-92, a cluster of miRNAs in the midst of the cancer network. , 2010, The international journal of biochemistry & cell biology.
[46] Lianbo Yu,et al. Detection of microRNA Expression in Human Peripheral Blood Microvesicles , 2008, PloS one.
[47] Z. Xu,et al. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients , 2007, Lupus.
[48] N. Shen,et al. Evidence for microRNA-mediated regulation in rheumatic diseases , 2009, Annals of the rheumatic diseases.